CARsgen Therapeutics Holdings Limited (2171.HK)
HKD 15.94
(2.57%)
HKD 15.94
(2.57%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.25 Billion CNY | -18.3% |
| 2022 | 2.76 Billion CNY | -21.19% |
| 2021 | 3.5 Billion CNY | 179.59% |
| 2020 | 1.25 Billion CNY | 284.84% |
| 2019 | 325.81 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 2.1 Billion CNY | 0.0% |
| 2024 Q1 | 2.1 Billion CNY | -6.85% |
| 2023 Q4 | 2.25 Billion CNY | 0.0% |
| 2023 FY | 2.25 Billion CNY | -18.3% |
| 2023 Q3 | 2.25 Billion CNY | -14.66% |
| 2023 Q2 | 2.64 Billion CNY | 0.0% |
| 2023 Q1 | 2.64 Billion CNY | -4.27% |
| 2022 Q2 | 3.27 Billion CNY | 0.0% |
| 2022 Q1 | 3.27 Billion CNY | -6.44% |
| 2022 FY | 2.76 Billion CNY | -21.19% |
| 2022 Q4 | 2.76 Billion CNY | 0.0% |
| 2022 Q3 | 2.76 Billion CNY | -15.76% |
| 2021 FY | 3.5 Billion CNY | 179.59% |
| 2021 Q4 | 3.5 Billion CNY | 0.0% |
| 2021 Q3 | 3.5 Billion CNY | -7.79% |
| 2021 Q2 | 3.8 Billion CNY | 0.0% |
| 2021 Q1 | 3.8 Billion CNY | 203.22% |
| 2020 FY | 1.25 Billion CNY | 284.84% |
| 2020 Q4 | 1.25 Billion CNY | 0.0% |
| 2020 Q3 | 1.25 Billion CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2019 FY | 325.81 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 409.99 Million HKD | -450.551% |
| CK Life Sciences Int'l., (Holdings) Inc. | 11.24 Billion HKD | 79.931% |